Jade C Newton1, Claire E Johnson1,2,3, Harry Hohnen1, Max Bulsara4, Angela Ives1, Sandy McKiernan5, Violet Platt6, Ruth McConigley1, Neli S Slavova-Azmanova7, Christobel Saunders1. 1. UWA Medical School, The University of Western Australia, Perth, Western Australia, Australia. 2. Monash Nursing and Midwifery, Monash University, Melbourne, Australia. 3. Eastern Health, Melbourne, Australia. 4. Institute for Health Research, University of Notre Dame, Perth, Western Australia, Australia. 5. Cancer Council Western Australia, Perth, Western Australia, Australia. 6. WA Cancer and Palliative Care Network, Perth, Western Australia, Australia. 7. UWA Medical School, The University of Western Australia, Perth, Western Australia, Australia. neli.slavova-azmanova@uwa.edu.au.
Abstract
PURPOSE: Out-of-pocket expenses (OOPE) can have a significant impact on patients' experiences of cancer treatment. This cross-sectional study sought to quantify the OOPEs experienced by rural cancer patients in Western Australia (WA), and determine factors that contributed to higher OOPE. METHODS: Four hundred people diagnosed with breast, lung, colorectal or prostate cancer who resided in selected rural regions of WA were recruited through the WA Cancer Registry and contacted at least 3 months after diagnosis to report the medical OOPE (such as surgery or chemotherapy, supportive care, medication and tests) and non-medical OOPE (such as travel costs, new clothing and utilities) they had experienced as a result of accessing and receiving treatment. Bootstrapped t tests identified demographic, financial and treatment-related factors to include in multivariate analysis, performed using log-linked generalised linear models with gamma distribution. RESULTS: After a median 21 weeks post-diagnosis, participants experienced an average OOPE of AU$2179 (bootstrapped 95% confidence interval $1873-$2518), and 45 (11%) spent more than 10% of their household income on these expenses. Participants likely to experience higher total OOPE were younger than 65 years (p = 0.008), resided outside the South West region (p = 0.007) and had private health insurance (PHI) (p < 0.001). CONCLUSIONS: Rural WA cancer patients experience significant OOPE following their diagnosis. The impact these expenses have on patient wellbeing and their treatment decisions need to be further explored.
PURPOSE: Out-of-pocket expenses (OOPE) can have a significant impact on patients' experiences of cancer treatment. This cross-sectional study sought to quantify the OOPEs experienced by rural cancerpatients in Western Australia (WA), and determine factors that contributed to higher OOPE. METHODS: Four hundred people diagnosed with breast, lung, colorectal or prostate cancer who resided in selected rural regions of WA were recruited through the WA Cancer Registry and contacted at least 3 months after diagnosis to report the medical OOPE (such as surgery or chemotherapy, supportive care, medication and tests) and non-medical OOPE (such as travel costs, new clothing and utilities) they had experienced as a result of accessing and receiving treatment. Bootstrapped t tests identified demographic, financial and treatment-related factors to include in multivariate analysis, performed using log-linked generalised linear models with gamma distribution. RESULTS: After a median 21 weeks post-diagnosis, participants experienced an average OOPE of AU$2179 (bootstrapped 95% confidence interval $1873-$2518), and 45 (11%) spent more than 10% of their household income on these expenses. Participants likely to experience higher total OOPE were younger than 65 years (p = 0.008), resided outside the South West region (p = 0.007) and had private health insurance (PHI) (p < 0.001). CONCLUSIONS: Rural WA cancerpatients experience significant OOPE following their diagnosis. The impact these expenses have on patient wellbeing and their treatment decisions need to be further explored.
Entities:
Keywords:
Cancer; Cross-sectional study; Financial toxicity; Health expenditure; Western Australia
Authors: Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees Journal: Breast Cancer Res Treat Date: 2010-10-26 Impact factor: 4.872
Authors: S Yousuf Zafar; Rebecca B McNeil; Catherine M Thomas; Christopher S Lathan; John Z Ayanian; Dawn Provenzale Journal: J Oncol Pract Date: 2014-12-16 Impact factor: 3.840
Authors: Laura E Leggett; Rachel G Khadaroo; Jayna Holroyd-Leduc; Diane L Lorenzetti; Heather Hanson; Adrian Wagg; Raj Padwal; Fiona Clement Journal: Medicine (Baltimore) Date: 2016-03 Impact factor: 1.889
Authors: Neli Slavova-Azmanova; Jade C Newton; Harry Hohnen; Claire E Johnson; Christobel Saunders Journal: Support Care Cancer Date: 2019-03-29 Impact factor: 3.603
Authors: Christopher J Longo; Margaret I Fitch; Laura Banfield; Paul Hanly; K Robin Yabroff; Linda Sharp Journal: Support Care Cancer Date: 2020-07-11 Impact factor: 3.603
Authors: Katharina M D Merollini; Louisa G Gordon; Joanne F Aitken; Michael G Kimlin Journal: Int J Environ Res Public Health Date: 2020-04-20 Impact factor: 3.390
Authors: Christopher J Longo; Margaret I Fitch; Jonathan M Loree; Linda E Carlson; Donna Turner; Winson Y Cheung; Darin Gopaul; Janet Ellis; Jolie Ringash; Maria Mathews; Jim Wright; Christiaan Stevens; David D'Souza; Robin Urquhart; Tuhin Maity; Fanor Balderrama; Evette Haddad Journal: Support Care Cancer Date: 2021-01-05 Impact factor: 3.603
Authors: Silvia Riva; Jane Bryce; Francesco De Lorenzo; Laura Del Campo; Massimo Di Maio; Fabio Efficace; Luciano Frontini; Diana Giannarelli; Lara Gitto; Elisabetta Iannelli; Claudio Jommi; Vincenzo Montesarchio; Francesca Traclò; Concetta Maria Vaccaro; Ciro Gallo; Francesco Perrone Journal: BMJ Open Date: 2019-09-09 Impact factor: 2.692
Authors: Annie Bygrave; Kate Whittaker; Christine Paul; Elizabeth A Fradgley; Megan Varlow; Sanchia Aranda Journal: Int J Environ Res Public Health Date: 2021-03-02 Impact factor: 3.390